Minerva Neurosciences, Inc. (NERV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 34.03M |
| Enterprise Value | 16.69M |
| P/E Ratio | -0.09 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -1.23 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.35 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.96 |
| Return On Equity | 1.68 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -293.42M |
| Net Income | -293.42M |
| Diluted EPS | -34.67 |
| Total Cash | 76.94M |
| Total Cash/Share | 1.56 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 33.02 |
| Book Value Per Share | -1.74 |
| 52-Week Change | -39.17 |
| 52-Week High | 8.8 |
| 52-Week Low | 1.96 |
| Moving Average 50 Days | 3.1 |
| Moving Average 200 Days | 4.83 |
| Average Volume | 198,764 |
| Shares Outstanding | 49.84M |
| % Held by Institutions | 91.06 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | June 21, 2022 |